| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443857 | European Journal of Cancer | 2014 | 8 Pages |
Abstract
Considerable international variation was found in DCIS detection. This variation could not be fully explained by variation in incidence nor in breast cancer detection rates. It suggests the potential for wide discrepancies in management of DCIS resulting in overtreatment of indolent DCIS or undertreatment of potentially curable disease. Comprehensive cancer registration is needed to monitor DCIS detection. Efforts to understand discrepancies and standardise management may improve care.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Elsebeth Lynge, Antonio Ponti, Ted James, OndÅej Májek, My von Euler-Chelpin, Ahti Anttila, Patricia Fitzpatrick, Alfonso Frigerio, Masaaki Kawai, Astrid Scharpantgen, Mireille Broeders, Solveig Hofvind, Carmen Vidal, Maria Ederra, Dolores Salas,